XENE$38.853.27%1.23
Xenon Pharmaceuticals Inc (XENE)
Date: 2026-11-03 16:00O: 38.04H: 39.00L: 37.78C: 38.85Vol: 526.6k
Xenon Pharmaceuticals Inc stock is traded at $38.85, with a volume of 536,749. It is up +3.27% in the last 24 hours and up +2.18% over the past month. Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Previous Close:
$37.62
Open:
$38.04
24h Volume:
536,749
Relative Volume:
0.41
Market Cap:
$3.76B
Revenue:
$7.50M
Net Income/Loss:
-$383.17M
P/E Ratio:
-
EPS:
-$4.70
Net Cash Flow:
-$307.84M
1W Performance:
+7.89%
1M Performance:
+2.18%
6M Performance:
-30.79%
1Y Performance:
-5.52%
1-Day Range:
$37.78$39.00
1-Week Range:
$35.37$38.35
52-Week Range:
$33.38$72.66
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Name
Xenon Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(604) 484-3300Address
200 - 3650 GILMORE WAY, BURNABY, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
Xenon Pharmaceuticals Inc Stock (XENE) Financials Data
Xenon Pharmaceuticals Inc Stock (XENE) Insider Trading
- Kelly Thomas PatrickSep 30 '26Chief Financial Officer
- Transaction
- Buy
- Cost
- $37.32
- #Shares
- 15,000
- Value ($)
- 559,740
- #Shares Total
- 15,000
- MORTIMER IANSep 30 '26PRESIDENT & CEO
- Transaction
- Buy
- Cost
- $37.38
- #Shares
- 30,000
- Value ($)
- 1,121,400
- #Shares Total
- 49,923
- Svoronos DawnSep 01 '26Director
- Transaction
- Option Exercise
- Cost
- $8.15
- #Shares
- 5,144
- Value ($)
- 41,924
- #Shares Total
- 31,373
- CHRISTOPHER KENNEYAug 28 '26Officer
- Transaction
- Proposed Sale
- Cost
- $61.93
- #Shares
- 7,068
- Value ($)
- 437,721
- #Shares Total
- 0
- KENNEY CHRISTOPHER JOHNAug 28 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $60.25
- #Shares
- 7,068
- Value ($)
- 425,829
- #Shares Total
- 2
- GANNON STEVENAug 11 '26Director
- Transaction
- Sale
- Cost
- $64.06
- #Shares
- 10,000
- Value ($)
- 640,550
- #Shares Total
- 1,870
- STEVEN GANNONAug 11 '26Director
- Transaction
- Proposed Sale
- Cost
- $64.06
- #Shares
- 10,000
- Value ($)
- 640,553
- #Shares Total
- 0
- GARY PATOUJun 05 '26Director
- Transaction
- Proposed Sale
- Cost
- $52.99
- #Shares
- 1,322
- Value ($)
- 70,053
- #Shares Total
- 0
- PATOU GARYJun 05 '26Director
- Transaction
- Sale
- Cost
- $53.14
- #Shares
- 1,322
- Value ($)
- 70,251
- #Shares Total
- 24,896
- Cannon GillianJun 05 '26Director
- Transaction
- Sale
- Cost
- $53.14
- #Shares
- 1,190
- Value ($)
- 63,237
- #Shares Total
- 1,455
